T1	DRUG 18 31	免疫チェックポイント阻害薬
T2	DRUG 32 35	ＩＣＩ
T3	DRUG 154 157	ＩＣＩ
T4	DRUG 216 219	ＩＣＩ
T5	DRUG 220 225	ニボルマブ
T6	DRUG 226 232	イピリムマブ
T7	DRUG 261 266	パゾパニブ
T8	DRUG 293 298	パゾパニブ
T9	DRUG 309 312	ＰＳＬ
T10	DRUG 459 472	ミコフェノール酸モフェチル
T11	DRUG 473 476	ＭＭＦ
T12	DRUG 518 523	ステロイド
T13	DRUG 548 555	ステロイド治療
T14	DRUG 644 647	ＭＭＦ
T15	DRUG 730 737	免疫抑制剤治療
T16	DISORDER 7 14	様々な悪性腫瘍
T17	DISORDER 95 103	免疫関連有害事象
T18	DISORDER 104 133	ｉｍｍｕｎｅ－ｒｅｌａｔｅｄ　ａｄｖｅｒｓｅ　ｅｖｅｎｔｓ
T19	DISORDER 136 140	ｉｒＡＥ
T20	DISORDER 161 173	著明な胆汁うっ滞性肝不全
T21	DISORDER 202 206	腎細胞癌
T22	DISORDER 207 213	胸膜転移再発
T23	DISORDER 278 281	肝障害
T24	DISORDER 282 284	黄疸
T25	OPINION 249 253	病勢増悪
T26	DISORDER 325 327	黄疸
T27	OPINION 328 330	増悪
T28	DISORDER 367 369	黄疸
T29	DISORDER 387 399	慢性非化膿性破壊性胆管炎
T30	DISORDER 400 408	著明な胆汁うっ滞
T31	DISORDER 412 416	ＰＢＣ様
T32	DISORDER 444 448	ｉｒＡＥ
T33	DISORDER 427 429	浸潤
T34	OPINION 489 496	全身状態の悪化
T35	OTHER 499 501	永眠
T36	DISORDER 510 517	肝関連ｉｒＡＥ
T37	DISORDER 565 572	肝関連ｉｒＡＥ
T38	DISORDER 581 585	胆管障害
T39	DISORDER 596 600	胆管障害
T40	DISORDER 603 610	肝関連ｉｒＡＥ
T41	DISORDER 696 700	ｉｒＡＥ
T42	DISORDER 703 708	肝障害症例
T44	TEST 382 385	肝生検
T45	OPINION 303 307	改善なく
T46	MEASURE 312 316	６０ｍｇ
T47	DRUG 351 361	ステロイドパルス療法
T48	OPINION 370 380	改善は得られなかった
T50	DRUG 540 545	パルス療法
T51	CHANGE_TRIGGER 270 272	開始
T53	CHANGE_TRIGGER 255 257	中止
T54	PERSONAL_INFORMATION 199 201	男性
T55	PERSONAL_INFORMATION 196 199	８３歳
T56	TIME 4 6	近年
T57	OPINION 45 56	有効性が認められている
T58	ANATOMY 87 94	さまざまな臓器
T60	TIME 241 243	４回
A2	Temporality T60 frequency
T61	TIME 486 489	数日後
T62	TIME 586 588	近年
T63	TIME 693 695	今後
A3	Temporality T63 point
T65	TIME 727 730	早期の
T59	OTHER 556 559	抵抗性
T66	OTHER 611 619	ステロイド抵抗性
T67	DISORDER 632 642	ステロイド抵抗性症例
T68	OPINION 648 650	有効
T43	MEASURE 439 441	陽性
T49	TEST 436 439	ＣＤ８
A4	Sentiment T57 neutral
T69	DISORDER 58 66	免疫抑制シグナル
A5	Sentiment T45 negative
A6	Sentiment T48 negative
A7	Sentiment T68 positive
T70	OPINION 675 691	効果を評価することはできなかった
A8	Sentiment T70 neutral
R1	CAUSED Arg1:T3 Arg2:T20	
R2	MISC Arg1:T21 Arg2:T22	
R3	REFERS_TO Arg1:T4 Arg2:T5	
R4	REFERS_TO Arg1:T4 Arg2:T6	
R7	TREATMENT_FOR Arg1:T7 Arg2:T22	
R5	TREATMENT_FOR Arg1:T4 Arg2:T22	
R6	SIGNALS_CHANGE_OF Arg1:T53 Arg2:T5	
A10	Drug_Changes T4 stopped
A11	Drug_Changes T7 started
R8	SIGNALS_CHANGE_OF Arg1:T51 Arg2:T7	
T52	CHANGE_TRIGGER 298 300	中止
A1	Drug_Changes T8 stopped
R9	HAS_DOSAGE Arg1:T9 Arg2:T46	
R10	TREATMENT_FOR Arg1:T9 Arg2:T23	
R12	SIGNALS_CHANGE_OF Arg1:T52 Arg2:T8	
R13	HAS_RESULT Arg1:T44 Arg2:T29	
R14	HAS_RESULT Arg1:T44 Arg2:T30	
R15	REFERS_TO Arg1:T10 Arg2:T11	
R16	EXAMINED_WITH Arg1:T33 Arg2:T49	
R17	HAS_RESULT Arg1:T49 Arg2:T43	
R19	TREATMENT_FOR Arg1:T10 Arg2:T31	
R21	TREATMENT_FOR Arg1:T47 Arg2:T23	
R20	IS_OPINION_ABOUT Arg1:T48 Arg2:T28	
R22	REFERS_TO Arg1:T13 Arg2:T47	
A12	Temporality T62 point
R23	TREATMENT_FOR Arg1:T14 Arg2:T67	
R24	IS_OPINION_ABOUT Arg1:T70 Arg2:T67	
R27	REFERS_TO Arg1:T67 Arg2:T37	
R25	HAS_RESULT Arg1:T44 Arg2:T31	
R29	SIGNALS_CHANGE_OF Arg1:T53 Arg2:T6	
R26	HAS_TIME Arg1:T4 Arg2:T60	
R28	MISC Arg1:T27 Arg2:T26	
R11	TREATMENT_FOR Arg1:T9 Arg2:T24	
R30	TREATMENT_FOR Arg1:T47 Arg2:T24	
R31	HAS_RESULT Arg1:T44 Arg2:T32	
R32	EXAMINED_WITH Arg1:T23 Arg2:T44	
R34	REFERS_TO Arg1:T13 Arg2:T50	
R35	REFERS_TO Arg1:T12 Arg2:T13	
R36	MISC Arg1:T59 Arg2:T36	
R37	IS_OPINION_ABOUT Arg1:T25 Arg2:T21	
A9	Sentiment T25 negative
A13	Sentiment T27 negative
A14	Sentiment T34 negative
T64	OPINION 709 711	増加
A15	Sentiment T64 negative
R18	MISC Arg1:T34 Arg2:T61	
R33	MISC Arg1:T35 Arg2:T61	
